Hiroki Kiyohara

7PUBLICATIONS
31CO-AUTHORS
GlycoconjugatesPacific Peoples health and wellbeing not elsewhere classifiedPredictive and prognostic markersEpidemiological methodsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 17, 2025
Leucine-rich alpha-2 glycoprotein in combination with C-reactive protein for predicting endoscopic activity in Crohn's disease: a single-centre, cross-sectional study.

Yoshiaki Takada, Hiroki Kiyohara, Yohei Mikami

|Jul 09, 2024
Reply to "Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-19".

Yuta Matsubara, Hiroki Kiyohara

|Apr 24, 2024
Efficacy of Dose Escalation of Oral 5-Aminosalicylic Acid for Ulcerative Colitis With a Mayo Endoscopic Subscore of 1: An Open Label Randomized Controlled Trial.

Tomohiro Fukuda, Yasuhiro Aoki, Hiroki Kiyohara

|Apr 23, 2024
Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing.

Tomohiro Fukuda, Hajime Yamazaki, Yusuke Miyatani

|Jan 25, 2024
Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study.

Yuta Matsubara, Hiroki Kiyohara, Yohei Mikami

|Oct 12, 2023
Immunomodulators after the discontinuation of anti-tumor necrosis factor-alpha antibody treatment and relapse in ulcerative colitis: A multicenter cohort study.

Kunio Asonuma, Keiji Ozeki, Hajime Yamazaki

Pageof 2

Frequent Collaborators

2 joint publications

Katsuyoshi Ando

2 joint publications

Kaoru Takabayashi

2 joint publications

Naoki Hosoe

2 joint publications

Kosaku Nanki